by MM360 Staff | Jun 3, 2025 | Uncategorized
Source: ASCO Daily News Dr. John Sweetenham shares highlights from Day 5 of the 2025 ASCO Annual Meeting, including data from large trials in advanced malignant melanoma and mCSPC plus a new approach to first-line treatment for patients with multiple myeloma who are...
by MM360 Staff | Jun 3, 2025 | Uncategorized
Source: CureToday articles Imdelltra improved survival and quality of life versus chemotherapy as second-line treatment for small cell lung cancer, reinforcing it as a new SOC. Read More
by MM360 Staff | Jun 3, 2025 | Uncategorized
Source: CureToday articles Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer. Read More
by MM360 Staff | Jun 3, 2025 | Uncategorized
Source: CureToday articles The FDA approved Nubeqa for metastatic castration-sensitive prostate cancer based on significantly improved radiographic progression-free survival data. Read More
by MM360 Staff | Jun 3, 2025 | Uncategorized
Source: CureToday articles COCOON dermatologic management lessened skin side effects and improved quality of life versus standard care for patients with lung cancer. Read More
by MM360 Staff | Jun 3, 2025 | Uncategorized
Source: CureToday articles I’m here to prove that powerful phrase; after nearly 16 years living with incurable cancer, I know there’s more to my story than the statistics. Read More
